UNSPSC 41202039: Mycobacterium tuberculosisimmunofluorescent reagents

In this classification, Mycobacterium tuberculosis immunofluorescent reagents are devices used in test to identify specific Mycobacterium tuberculosis immunofluorescent reagents antibodies in serum. US FDA regulates Mycobacterium tuberculosis immunofluorescent reagents under 21 CFR 866.3370 and under FDA product code GRT.

UNSPSC 41202039 Mycobacterium tuberculosis immunofluorescent reagents is a Commodity code that in practice covers a much broader spectrum of diagnostic reagents and testing supplies than its narrow name suggests. State and local health departments, counties, and municipal public health agencies are using this code to procure HIV test kits, syphilis reagents, drugs-of-abuse testing supplies, and laboratory testing services—encompassing rapid diagnostic kits, confirmatory reagents, calibrators, controls, consumables, and the associated analyzer maintenance required to operate existing diagnostic platforms. The issuing bodies are primarily state health departments (Illinois Department of Public Health, Texas Department of Criminal Justice), county health and community supervision agencies (Collin County, Gwinnett County), and municipal public health programs (City of Austin). Recent activity shows repeat procurement by the Illinois Department of Public Health for Abbott analyzer reagents and by Collin County for both drug testing and general laboratory services.

Geographic concentration is heaviest in Texas and Illinois. The Illinois Department of Public Health has posted multiple change orders and emergency procurements for Abbott HIV and Syphilis reagents since May 2026, including a $38,079.50 emergency sole-source contract to Abbott Laboratories Inc. and a $900,000 change order (raising from $525,000) to increase statewide sexually transmitted infection testing volume through the Carbondale Laboratory. Texas activity includes Collin County's RFP for offender specimen collection and drug testing services (RFP 2026-327, due July 23, 2026, estimated value $600,000 over five years) and offender drug screening at approximately 25,031 tests annually; Gwinnett County, Georgia issued an RFP for drug testing supplies compatible with an existing drugs-of-abuse analyzer (RFP PE77023NONST2027000000764, due October 14, 2026); and the City of Austin posted two HIV test kit IFBs in June and August 2026 (estimated 375 Abbott Determine test kits and 79 control kits annually). The Illinois Department of Public Health procurement officer Mike Caceres and Alejandro Arroyo at the City of Austin are recurring contacts in recent notices. The code shows sustained demand for proprietary reagent replenishment tied to in-place analyzer infrastructure, emergency restocking, and expansion of testing volumes to meet public health surveillance and offender-monitoring demand.